Form 8-K - Current report:
SEC Accession No. 0001193125-25-154143
Filing Date
2025-07-02
Accepted
2025-07-01 17:47:57
Documents
22
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d822787d8k.htm   iXBRL 8-K 28515
2 EX-10.1 d822787dex101.htm EX-10.1 446943
6 GRAPHIC g822787g02g02.jpg GRAPHIC 11827
7 GRAPHIC g822787g50g50.jpg GRAPHIC 49494
8 GRAPHIC g822787g52g52.jpg GRAPHIC 49611
9 GRAPHIC g822787g53g53.jpg GRAPHIC 142486
10 GRAPHIC g822787g59g59.jpg GRAPHIC 420808
11 GRAPHIC g822787g61g61.jpg GRAPHIC 385099
12 GRAPHIC g822787g63g63.jpg GRAPHIC 400342
13 GRAPHIC g822787g65g65.jpg GRAPHIC 380888
14 GRAPHIC g822787g66g66.jpg GRAPHIC 49184
  Complete submission text file 0001193125-25-154143.txt   3323243

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crgx-20250627.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20250627_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20250627_pre.xml EX-101.PRE 11700
24 EXTRACTED XBRL INSTANCE DOCUMENT d822787d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 251097633
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)